阿莫西林与莫西沙星治疗幽门螺杆菌胃病的有效性及药理作用分析  被引量:3

Analysis on effectiveness and pharmacological action of amoxicillin and moxifloxacin in the treatment of helicobacter pylori gastric diseases

在线阅读下载全文

作  者:彭奋飞[1] 欧阳炜[1] PENG Fenfei;OUYANG Wei(Department of Pharmacy,Guangdong Second Hospital of Traditional Chinese Medicine,Guangzhou 510095,China)

机构地区:[1]广东省第二中医院药学部,广东广州510095

出  处:《中国医药科学》2018年第24期35-37,共3页China Medicine And Pharmacy

摘  要:目的评价阿莫西林与莫西沙星治疗幽门螺杆菌胃病的有效性,分析其药理作用。方法选取我院2016年1月~2017年12月期间收治的幽门螺杆菌胃病患者128例,根据随机双盲法分为A组与B组各64例,分别采取莫西沙星、阿莫西林治疗,比较两组患者治疗效果、HP根除率及药物不良反应。结果A组总有效率96.88%高于B组总有效率79.69%,幽门螺杆菌根除率89.06%高于B组幽门螺杆菌根除率64.06%,治疗后胃痛症状评分低于对照组,不良反应发生率3.13%低于B组不良反应发生率14.06%,差异有统计学意义(P <0.05)。结论与阿莫西林相比,莫西沙星治疗幽门螺杆菌胃病更为有效,HP根除率高,临床价值高,值得临床进一步推广并使用。Objective To evaluate the effectiveness of amoxicillin and moxifloxacin in the treatment of helicobacter pylori gastric diseases to analyze its pharmacological action. Methods One hundred and twenty-eight patients with helicobacter pylori gastric diseases who were admitted and treated in our hospital from January 2016 to December2017 were selected.According to the randomized double-blind method,they were divided into group A and group B,with 64 cases in each group.Group A was treated with moxifloxacin while group B was treated with amoxicillin.The curative effect,HP eradication rate and adverse reactions of drugs of patients in two groups were compared. Results The total effective rate of group A was 96.88%,higher than that of group B 79.69%.The eradication rate of helicobacter pylori in group A was 89.06%,higher than that of group B 64.06%.The symptom score of stomachache after treatment of group A was lower than that of the control group.The incidence of adverse reactions in group A was 3.13%,lower than that of group B 14.06%.The difference was statistically significant(P < 0.05). Conclusion Compared with amoxicillin,moxifloxacin is more effective in the treatment of helicobacter pylori stomach disease.HP has a high eradication rate and high clinical value.It is worthy of further promotion and use in clinical practice.

关 键 词:幽门螺杆菌 胃病 阿莫西林 莫西沙星 药理作用 

分 类 号:R573[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象